Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Healthy men to swallow radioactive drug for science

NCT ID NCT07463053

Not yet recruiting Knowledge-focused Sponsor: Jemincare Source: ClinicalTrials.gov ↗

First seen Mar 16, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This early-stage study in 8 healthy Chinese men aims to understand how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive a radioactive form of the drug to track its path. This study does not offer any treatment benefit; it is designed purely to gather important information for future research on polycystic kidney disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

Explore the condition pages connected to this study.